Anaptysbio (ANAB) Other financing activities (2016 - 2021)
Anaptysbio (ANAB) posted Other financing activities of $241000.0 for Q3 2021, down 56.5% on a QoQ basis from $554000.0 in Q2 2021, and down 8.37% year-over-year from $263000.0 in Q3 2020.
Anaptysbio (ANAB) Other financing activities (2016 - 2021) Analysis & Trends
Anaptysbio's Other financing activities history runs 6 years deep, the most recent figure standing at $241000.0 for Q3 2021.
- Quarterly Other financing activities fell 8.37% year-over-year to $241000.0 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $1.1 million (up 224.63% YoY) and the FY2020 annual result came in at $496000.0, changed N/A from the prior year.
- Other financing activities was $241000.0 for Q3 2021 at Anaptysbio, down from $554000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $1.4 million in Q2 2018 and bottomed at -$2.1 million in Q4 2018.
- A 5-year average of $108947.4 and a median of $215000.0 in 2019 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 3844.44% in 2017, while the deepest fall reached 1637.5% in 2017.
- Anaptysbio's Other financing activities stood at -$278000.0 in 2017, then plunged by 641.73% to -$2.1 million in 2018, then soared by 39.72% to -$1.2 million in 2019, then surged by 110.14% to $126000.0 in 2020, then jumped by 91.27% to $241000.0 in 2021.
- Business Quant data shows ANAB's Other financing activities at $241000.0 in Q3 2021, $554000.0 in Q2 2021, and $167000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Anaptysbio | 1.58 Bn | 1.29 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 241,000.00 |
| Sep 30, 2021 | 241,000.00 |
| Jun 30, 2021 | 554,000.00 |
| Jun 30, 2021 | 554,000.00 |
| Mar 31, 2021 | 167,000.00 |
| Mar 31, 2021 | 167,000.00 |
| Dec 31, 2020 | 126,000.00 |
| Dec 31, 2020 | 126,000.00 |
| Sep 30, 2020 | 263,000.00 |
| Sep 30, 2020 | 263,000.00 |
| Jun 30, 2020 | 71,000.00 |
| Jun 30, 2020 | 71,000.00 |
| Mar 31, 2020 | 36,000.00 |
| Mar 31, 2020 | 36,000.00 |
| Dec 31, 2019 | -1.24 Mn |
| Dec 31, 2019 | -1.24 Mn |
| Sep 30, 2019 | 454,000.00 |
| Sep 30, 2019 | 454,000.00 |
| Jun 30, 2019 | 215,000.00 |
| Jun 30, 2019 | 215,000.00 |